Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
about
Update in diffuse parenchymal lung disease, 2013Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.MicroRNA regulatory networks in idiopathic pulmonary fibrosis.Role of ID Proteins in BMP4 Inhibition of Profibrotic Effects of TGF-β2 in Human TM Cells.Dynamic expression of transformating growth factor-β1 and caveolin-1 in the lung of Bleomycin-induced interstitial lung disease.Profibrogenic phenotype in caveolin-1 deficiency via differential regulation of STAT-1/3 proteins.Deletion of c-FLIP from CD11b(hi) Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis.A novel lnc-PCF promotes the proliferation of TGF-β1-activated epithelial cells by targeting miR-344a-5p to regulate map3k11 in pulmonary fibrosis.Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression.Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148.Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis.MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis.
P2860
Q35153423-A11AF400-6996-4324-9959-9C4A45B50139Q35750862-665AB543-54BB-4A59-B8A5-8907081F3AEDQ35766401-627BBFD0-83FF-4FB6-A77D-80F94B3EE4FAQ38306947-500720F1-761E-4D98-9DEA-9FBC3D62182BQ38761751-6A6334E9-80D7-4DD5-AFF3-1B2E6B2378CEQ41303019-3A672F83-1A1F-4C91-A24B-458D7DE7E297Q42466342-C1A6FB9B-EAA1-4595-BB4A-C002B4D39E1DQ42777505-C418A070-B5C5-4A71-A3D8-6BDA574E8F62Q47149080-4C46685C-8638-4DF7-95AF-7CB6B5D5F894Q47756248-CF0223AE-8166-4716-A24E-7755F7CB0701Q47778947-AB680801-92AF-4017-A101-7A30F1B87B7AQ47995268-258316DF-82E5-410D-8414-B6FA051C981FQ52578942-08DE4BDB-39A7-48DD-859D-9DE72BB2F2ECQ55022191-B4F9A17F-488D-49F2-96C7-683DA760D18B
P2860
Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Syndecan-2 exerts antifibrotic ...... ng growth factor-β1 signaling.
@en
Syndecan-2 exerts antifibrotic ...... ng growth factor-β1 signaling.
@nl
type
label
Syndecan-2 exerts antifibrotic ...... ng growth factor-β1 signaling.
@en
Syndecan-2 exerts antifibrotic ...... ng growth factor-β1 signaling.
@nl
prefLabel
Syndecan-2 exerts antifibrotic ...... ng growth factor-β1 signaling.
@en
Syndecan-2 exerts antifibrotic ...... ng growth factor-β1 signaling.
@nl
P2093
P2860
P1476
Syndecan-2 exerts antifibrotic ...... ng growth factor-β1 signaling.
@en
P2093
Andrew J Goodwin
Avignat S Patel
Bernadette R Gochuico
Cristobal F Risquez
Danielle Morse
Eric M Billings
Guoying Yu
Isis E Fernandez
Ivan O Rosas
Jeffrey A Haspel
P2860
P304
P356
10.1164/RCCM.201303-0434OC
P407
P577
2013-10-01T00:00:00Z